title: Human Papillomavirus Vaccination Among Adults and Children in 5 US States.
abstract: BACKGROUND
  The Centers for Disease Control and Prevention Advisory Committee for Immunization Practices has recommended human papillomavirus (HPV) vaccines for use in children and young adults for preventing HPV-related diseases, but HPV vaccine coverage is low in the United States.
  
  
  OBJECTIVE
  To assess HPV vaccination among US adults and children and to identify characteristics associated with HPV vaccination.
  
  
  METHODS
  We used the 2010 Behavioral Risk Factors Surveillance System data to examine HPV vaccine initiation and completion among adults aged 18 to 26 years and children aged 9 to 17 years in 5 US states. We performed a multivariate logistic regression to evaluate factors associated with HPV vaccination.
  
  
  RESULTS
  We assessed the HPV vaccination status of 706 women and 560 men and 2201 girls and 2292 boys. In 2010, a total of 258 (41.6%) women and 21 (4.3%) men had initiated HPV vaccination. Of those vaccinated women, 182 (75%) completed the 3-dose vaccine series. Rural residence (adjusted odds ratio [aOR] = 0.37) and not having a Papanicolaou test (aOR = 0.44) were negatively associated with HPV vaccine initiation among women. Women who were aged 18 to 20 years (aOR = 2.93) were more likely to complete HPV vaccination. A total of 612 (24.6%) girls and 86 (5.2%) boys received 1 or more doses of HPV vaccines; 308 (50.3%) vaccinated girls and 14 (10.8%) vaccinated boys completed the vaccine series. Younger age (9-12 years: aOR = 0.09) and not receiving a seasonal influenza vaccine (aOR = 0.44) were negatively related to HPV vaccine initiation in girls. Girls were less likely to initiate and complete HPV vaccination if their parents did not have a routine checkup within 1 year.
  
  
  CONCLUSIONS
  HPV vaccination in the United States remains below the Healthy People 2020 objective (80%). To increase HPV vaccination, strategies still need to focus on improving access to HPV vaccines and utilization of health services.
authors.affiliation: Departments of Medicine (Drs Du and McCall-Hosenfeld), Public Health Sciences (Drs Du, McCall-Hosenfeld, and Lengerich and Mr Camacho), Microbiology and Immunology (Dr Meyers), and Pathology (Dr Christensen), The Pennsylvania State University College of Medicine, Hershey.
authors.forename: Ping
authors.initials: P
authors.lastname: Du
authors.forename: Fabian
authors.initials: F
authors.lastname: Camacho
authors.forename: Jennifer
authors.initials: J
authors.lastname: McCall-Hosenfeld
authors.forename: Eugene
authors.initials: E
authors.lastname: Lengerich
authors.forename: Craig M
authors.initials: CM
authors.lastname: Meyers
authors.forename: Neil D
authors.initials: ND
authors.lastname: Christensen
mesh_terms: D000293:Adolescent; D000328:Adult; D040343:Behavioral Risk Factor Surveillance System; D002648:Child; D003237:Connecticut; D005260:Female; D006801:Humans; D008297:Male; D032541:Mass Vaccination / Q000592:standards; D008404:Massachusetts; D008875:Middle Aged; D030361:Papillomavirus Infections / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000494:pharmacology / Q000627:therapeutic use*; D012237:Rhode Island; D011795:Surveys and Questionnaires; D014903:West Virginia; D014959:Wyoming
chemical_list: D053918:Papillomavirus Vaccines